Vaishali Pharma Limited (NSE:VAISHALI)
India · Delayed Price · Currency is INR 7.35
-0.12 (-1.61%)
Jul 30, 2026, 3:29 PM IST
Vaishali Pharma Market Cap
Vaishali Pharma has a market cap or net worth of 958.9 million as of July 30, 2026. Its market cap has decreased by -35.64% in one year.
Market Cap
958.90M
Enterprise Value
1.13B
Revenue
1.09B
Ranking
n/a
PE Ratio
22.97
Stock Price
7.35
ChartMarket Cap Chart
Since October 11, 2017, Vaishali Pharma's market cap has increased from 286.62M to 958.90M, an increase of 234.56%. That is a compound annual growth rate of 14.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 958.90M | -14.73% |
| Dec 31, 2025 | 1.12B | -46.84% |
| Dec 31, 2024 | 2.12B | 9.71% |
| Dec 29, 2023 | 1.93B | 31.85% |
| Dec 30, 2022 | 1.46B | 286.75% |
| Dec 31, 2021 | 378.08M | -48.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 15.56B |
| Sigachi Industries | 9.91B |
| Bafna Pharmaceuticals | 6.10B |
| Valiant Laboratories | 3.35B |
| Nectar Lifesciences | 1.99B |
| Brooks Laboratories | 1.76B |
| Alpa Laboratories | 1.42B |
| Balaxi Pharmaceuticals | 1.33B |